Shambhavi Naik quoted in Business Standard

Takshashila’s Shambhavi Naik was quoted in Business Standard on the need to streamline research on CRISPR gene-editing technology.

Talking about the guidelines existing on Therapeutic diagnostics and products, Dr Shambhavi Nayak, Head of Research, Takshashila Institution expressed the vagueness in the policy.

The Government should move to a facilitator role, making markets more accessible

You can read the full article here.